GERAGHTY JAMES A
SEC insider (Form 3/4/5 filer). CIK 0001239746. Director at Fulcrum Therapeutics, Inc. (FULC) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in CAMBRIDGE, MA.
Companies GERAGHTY JAMES A has filed insider reports for
- Fulcrum Therapeutics, Inc. (FULC): Director
- Voyager Therapeutics, Inc. (VYGR): Director
- PIERIS PHARMACEUTICALS, INC. (PIRS): Director
GERAGHTY JAMES A
CIK: 0001239746
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 30, 2026FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
32K shares- - Jun 9, 2026VYGR
Voyager Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
30K shares- - Jun 26, 2025FULC
Fulcrum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
36K shares- - Jun 3, 2025VYGR
Voyager Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
24K shares- - Dec 12, 2024PIRS
PIERIS PHARMACEUTICALS, INC.
DispositionDirect1 shares at avg. $0.01$0.01 - Aug 7, 2024PIRS
PIERIS PHARMACEUTICALS, INC.
PurchaseDirect1 shares at avg. $1.00$1
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 |  FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 32,000 | - | - | Direct |
| Jun 9, 2026 |  VYGR Voyager Therapeutics, Inc. | Award Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| Jun 26, 2025 | FULC Fulcrum Therapeutics, Inc. | Award Stock Option (right to buy) | 36,000 | - | - | Direct |
| Jun 3, 2025 | VYGR Voyager Therapeutics, Inc. | Award Stock Option (Right to Buy) | 24,000 | - | - | Direct |
| Dec 12, 2024 |  PIRS PIERIS PHARMACEUTICALS, INC. | Disposition | 1 | $0.01 | $0 | Direct |
| Aug 7, 2024 | PIRS PIERIS PHARMACEUTICALS, INC. | Purchase | 1 | $1.00 | $1 | Direct |
1-6 of 6 transactions